Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Hyperandrogenism is diagnosed using clinical signs, lab tests, and imaging.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Haematospermia is usually harmless but needs careful checking to ease anxiety and find any serious causes.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Men with hair loss are more likely to have cholesterol issues and sleep apnea.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Pesticide exposure may increase the risk of hypospadias in males.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Individuals with male pseudohermaphroditism often do better raised as females with early surgery.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.